PPARs: therapeutic targets for metabolic disease
Top Cited Papers
- 1 May 2005
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 26 (5) , 244-251
- https://doi.org/10.1016/j.tips.2005.03.003
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Regulation of Muscle Fiber Type and Running Endurance by PPARδPLoS Biology, 2004
- Peroxisome Proliferator-Activated Receptors and AtherogenesisCirculation Research, 2004
- MK-0767, a novel dual PPARα/γ agonist, displays robust antihyperglycemic and hypolipidemic activitiesBiochemical and Biophysical Research Communications, 2004
- Peroxisome Proliferator-Activated Receptor α Agonists Increase Nitric Oxide Synthase Expression in Vascular Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Peroxisome Proliferator-Activated Receptor γ: Implications for Cardiovascular DiseaseHypertension, 2004
- Activation of PPARδ alters lipid metabolism in db/db miceFEBS Letters, 2000
- Activation of PPARα or γ Reduces Secretion of Matrix Metalloproteinase 9 but Not Interleukin 8 from Human Monocytic THP-1 CellsBiochemical and Biophysical Research Communications, 2000
- Peroxisome proliferator–activated receptor α mediates the adaptive response to fastingJournal of Clinical Investigation, 1999
- Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.Journal of Clinical Investigation, 1995
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994